Anebulo Historical Cash Flow
| ANEB Stock | USD 1.36 0.04 2.86% |
Analysis of Anebulo Pharmaceuticals cash flow over time is an excellent tool to project Anebulo Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 129.3 K or Capital Expenditures of 0.0 as it is a great indicator of Anebulo Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Anebulo |
About Anebulo Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Anebulo balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Anebulo's non-liquid assets can be easily converted into cash.
Anebulo Pharmaceuticals Cash Flow Chart
Add Fundamental
Most accounts from Anebulo Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Anebulo Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.At present, Anebulo Pharmaceuticals' Change To Netincome is projected to increase significantly based on the last few years of reporting. The current year's Begin Period Cash Flow is expected to grow to about 13.4 M, whereas Change In Cash is projected to grow to (7 M).
Anebulo Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Anebulo Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Anebulo Pharmaceuticals cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 17.0M | (5.4M) | (3.3M) | (8.2M) | (7.3M) | (7.0M) | |
| Free Cash Flow | (4.9M) | (5.4M) | (9.7M) | (8.1M) | (7.3M) | (7.6M) | |
| Change In Working Capital | (1.4M) | 907.8K | 1.2M | (799.3K) | (919.1K) | (873.2K) | |
| Other Cashflows From Financing Activities | (821.6K) | (317.1K) | (264.7K) | (62.4K) | (56.1K) | (53.3K) | |
| Other Non Cash Items | 26.6M | 209.9K | 731.0K | 151.2K | 136.1K | 129.3K | |
| Total Cash From Operating Activities | (4.9M) | (5.4M) | (9.7M) | (8.1M) | (7.3M) | (7.6M) | |
| Net Income | (30.3M) | (6.8M) | (11.7M) | (8.2M) | (9.4M) | (9.9M) | |
| End Period Cash Flow | 20.0M | 14.5M | 11.2M | 3.1M | 2.8M | 2.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anebulo Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anebulo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Anebulo Pharmaceuticals is measured differently than its book value, which is the value of Anebulo that is recorded on the company's balance sheet. Investors also form their own opinion of Anebulo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Anebulo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anebulo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Anebulo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anebulo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anebulo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anebulo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.